Momenta Pharmaceuticals' (MNTA) M254 is a Free Call Option - Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Danielle Brill reiterated an Overweight rating and $35.00 price target on Momenta Pharmaceuticals (NASDAQ: MNTA) noting that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
